Pharmaceutical Pricing—JAMA Talks With Mark Cuban

Key Points

• This conversation aims to highlight the challenges in pharmaceutical pricing and the need for more affordable options.
• Interview with Mark Cuban
• Discussion on the role of cost plus pricing
• Examination of market dynamics affecting drug pricing
• Insights into how cost plus drugs can improve affordability
• Discussion on the implications of current pharmaceutical pricing models
• Exploration of entrepreneurial solutions to enhance drug access